Abstract: HAspects of the present disclosure include crystalline bazedoxifene free base crystalline bazedoxifene acetate Form D and processes for their preparation. The drug compound having the adopted name "bazedoxifene acetate" has a chemical name 1 [4 (2 azepan 1 yl ethoxy)benzyl] 2 (4 hydroxyphenyl) 3 methyl 1 indol 5 ol acetic acid and has the chemical structure shown below as Formula I.
SOFT COPY ATTACHED IN PDF
| # | Name | Date |
|---|---|---|
| 1 | 1980-CHENP-2013-AbandonedLetter.pdf | 2018-09-07 |
| 1 | Form 5.pdf | 2013-03-18 |
| 2 | 1980-CHENP-2013-FER.pdf | 2018-02-23 |
| 2 | Form 3.pdf | 2013-03-18 |
| 3 | 1980-CHENP-2013.pdf | 2014-03-21 |
| 3 | Form 2.pdf | 2013-03-18 |
| 4 | 1980-CHENP-2013.pdf | 2014-03-21 |
| 4 | Form 2.pdf | 2013-03-18 |
| 5 | 1980-CHENP-2013-FER.pdf | 2018-02-23 |
| 5 | Form 3.pdf | 2013-03-18 |
| 6 | 1980-CHENP-2013-AbandonedLetter.pdf | 2018-09-07 |
| 6 | Form 5.pdf | 2013-03-18 |
| 1 | 1980_CHENP_2013_30-01-2018.pdf |